Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein

Nature Immunology

Volumn 2, Issue 10, 2001, Pages 939-946

  Liu, Weimin ^a   Quinto, Ileana ^a,b   Chen, Xueni ^a   Palmieri, Camillo ^a   Rabin, Ronald L ^c   Schwartz, Owen M ^c   Nelson, David L ^d   Scala, Giuseppe ^a,b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; BRUTON TYROSINE KINASE INHIBITOR; CALCIUM ION; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SRC PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CALCIUM MOBILIZATION; CELL MATURATION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY MECHANISM; X CHROMOSOME LINKED DISORDER; X LINKED AGAMMAGLOBULINEMIA;

AMINO ACID SEQUENCE; B-LYMPHOCYTES; CALCIUM; CARRIER PROTEINS; CELL LINE; HUMANS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN-TYROSINE KINASES; RNA, MESSENGER; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0034780366     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1001-939     Document Type: Article

References (53)

1. Role of Bruton's tyrosine kinase in immunodeficiency
2. Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells
3. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
4. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: Identification of a mutation which affects the same codon as is altered in immunodeficient xid mice
5. Agammaglobulinemia
6. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases
7. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice
8. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes
9. BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells
10. Ptdlns-3,4,5-P3: A regulatory nexus between tyrosine kinases and sustained calcium signals
11. Bruton's tyrosine kinase links the B cell receptor to nuclear factor κB activation
12. Bruton's tyrosine kinase is required for activation of 1κB kinase and nuclear factor κB in response to B cell receptor engagement
13. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement
14. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase
15. Xid-like phenotypes: A B cell signalosome takes shape
16. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage
17. Impaired expansion of mouse B cell progenitors lacking Btk
18. Activation of Tsk and Btk tyrosine kinases by G protein βγ subunits
19. The G protein G α12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain
20. Tec/Bmx non-receptor tyrosine kinases are involved in regulation of Rho and serum response factor by Gα12/13
21. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
22. Tec homology (TH) adjacent to the PH domain
23. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity
24. SHIP modulates immune receptor responses by regulating membrane association of Btk
25. Btk function in B cell development and response
26. Regulatory intramolecular association in a tyrosine kinase of the Tec family
27. The SH3 domain of Bruton's tyrosine kinase displays altered ligand binding properties when auto-phosphorylated in vitro
28. Regulation of Btk function by a major autophosphorylation site within the SH3 domain
29. Direct stimulation of Bruton's tyrosine kinase by G(q)-protein α-subunit
30. 2+ following B-cell receptor activation
31. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors
32. Analysis of signaling via surface immunoglobulin receptors on B cells from CBA/N mice
33. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity
34. The primary immunodeficiencies
35. BTKbase, mutation database for X-linked agammaglobulinemia (XLA)
36. Discordant phenotype in siblings with X-linked agammaglobulinemia
37. A novel mutation (Cys145→Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male
38. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C
39. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase
40. A new protein containing an SH2 domain that inhibits JAK kinases
41. A family of cytokine-inducible inhibitors of signalling
42. Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex
43. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection
44. Involvement of Bruton's tyrosine kinase in FcεRI-dependent mast cell degranulation and cytokine production
45. Rapid tyrosine phosphorylation and activation of Bruton's tyrosine/Tec kinases in platelets induced by collagen binding or CD32 cross-linking
46. Tyrosine phosphorylation of the Wiskott-Aldrich syndrome protein by Lyn and Btk is regulated by CDC42
47. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein β (NF-IL6) transcription factors
48. Molecular genetic analysis of X-linked hypogammaglobulinemia and isolated growth hormone deficiency
49. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase
50. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling
51. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN α and IFN γ, and is likely to autoregulate the p91 gene
52. Impaired generation of bone marrow B lymphocytes in mice deficient in C/EBPβ
53. The regulation of E2F by pRB-family proteins